Target intelligence / Profile preview

TOX high mobility group box family member 4 pseudogene 1 (TOX4P1)

Target
TOX4P1
Molecular classification
Pseudogene, Non-coding RNA (potential, see description)
01

Overview

**TOX4P1 (TOX high mobility group box family member 4 pseudogene 1)** is classified as a pseudogene, meaning it is a DNA sequence similar to a protein-coding gene (TOX4) but is nonfunctional and generally does not code for a protein[3][8]. It is not considered a therapeutic target, receptor, enzyme, transporter, or functional transcription factor. Pseudogenes may sometimes be transcribed into RNA and, in rare cases, can influence gene regulation at the RNA level, including microRNA (miRNA) decoy activity or generation of small interfering RNAs (siRNAs) impacting their cognate protein-coding genes[2][4]. However, there is no direct evidence that TOX4P1 specifically has any such regulatory role, nor any links to disease or drug interaction in current knowledge. Its main biological and clinical relevance is as a non-coding, likely nonfunctional, genomic element. **Note:** If the intent was to refer to the functional protein-coding gene, "TOX4 (TOX high mobility group box family member 4)," this is distinct from TOX4P1—the former is a transcription factor involved in chromatin structure and gene regulation[1].

Other names
TOX4P1
02

Biological functions

No direct protein-coding function (see description)Potential RNA-level regulation by pseudogene mechanisms
03

Disease associations

No direct role establishedPseudogenes in general can have regulatory roles related to cancer and other diseases, but no evidence for this pseudogene specifically[2][3][4][5]

Beyond the preview

Go deeper on TOX high mobility group box family member 4 pseudogene 1 (TOX4P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOX high mobility group box family member 4 pseudogene 1 (TOX4P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call